Levobupivacaine Medac (Levobupivacaine)

Levobupivacaine is a long‑acting amide local anesthetic administered via the epidural route to achieve regional nerve blockade for various clinical situations.

• Surgical anesthesia: provides regional anesthesia for operative procedures, facilitating muscle relaxation and analgesia.
• Labor analgesia: offers effective pain relief during childbirth while preserving maternal consciousness.
• Postoperative analgesia: reduces pain intensity after surgery, supporting early mobilization and recovery.
• Diagnostic procedures: enhances patient comfort during certain invasive examinations that require regional anesthesia.

• Levobupivacaine reversibly blocks voltage‑gated sodium channels on neuronal membranes, preventing the initiation and propagation of nerve impulses. By stabilizing the neuronal membrane, it inhibits depolarization, resulting in loss of sensation in the targeted area while preserving motor function at lower concentrations.

Levobupivacaine may cause a range of adverse reactions, from mild to severe, depending on patient factors and administration technique.

Common Side Effects

• Injection site pain or irritation.
• Transient numbness or tingling in the treated region.
• Mild hypotension due to sympathetic blockade.
• Headache, often post‑dural puncture.
• Nausea or vomiting.
• Temporary motor weakness.

Serious or Rare Side Effects

• Cardiovascular toxicity such as arrhythmias or cardiac arrest.
• Central nervous system toxicity including seizures or loss of consciousness.
• Allergic reactions ranging from rash to anaphylaxis.
• Persistent neurologic deficits.
• Methemoglobinemia (rare).

When using Levobupivacaine, clinicians should observe specific safety measures to minimize risk.

• Patient assessment: evaluate cardiac, hepatic and renal function before administration.
• Dose limitation: adhere to recommended maximum doses to avoid systemic toxicity.
• Monitoring: continuously monitor cardiovascular and neurologic status during and after injection.
• Contraindications: avoid use in patients with known hypersensitivity to amide local anesthetics.
• Drug interactions: be cautious with agents that may potentiate cardiac or CNS effects.
• Store at ambient temperature: keep in original container, protect from light and moisture.

Levobupivacaine can interact with other medications, altering its safety profile.

Major Interactions (Avoid)

• Other local anesthetics: concurrent use may increase risk of systemic toxicity.
• Beta‑blockers and calcium channel blockers: can enhance cardiac depressant effects.
• Monoamine oxidase inhibitors (MAOIs): may potentiate CNS toxicity.

Moderate Interactions (Monitor Closely)

• Anticonvulsants: may lower seizure threshold when combined with high doses.
• Diuretics: can affect plasma protein binding, altering free drug levels.
• Drugs affecting hepatic metabolism (e.g., CYP3A4 inhibitors): may increase plasma concentration of levobupivacaine.